Akebia Therapeutics Inc. buy yester
Start price
23.01.21
/
0%
€2.86
Target price
23.01.22
€3.00
Performance (%)
-38.46%
End price
24.01.22
€1.76
Summary
This prediction ended on 24.01.22 with a price of €1.76. The BUY prediction by yester for Akebia Therapeutics Inc. performed very badly with a performance of -38.46%.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Akebia Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
According to yester what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Higher risks for its business
Comments by yester for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Buy mit Kursziel 5,0
Kursziel geändert auf 6,0
Kursziel geändert auf 5,0
Kursziel geändert auf 3,0
In the thread Trading Akebia Therapeutics Inc.
Die von yester gewählte maximale Laufzeit wurde überschritten